Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Asparagus extract** is derived from species such as Asparagus officinalis (garden asparagus) and Asparagus cochinchinensis (Chinese asparagus), and is used primarily as a dietary supplement for its proposed diuretic, hypoglycemic, antihypertensive, hypocholesterolemic, antioxidant, anti-inflammatory, neuroprotective, and anticancer effects[1][2][3]. Mechanistic studies suggest asparagus extract acts via modulation of various pathways including ACE inhibition (antihypertensive effect), mitochondrial-mediated apoptosis (anticancer effect), and inhibition of inflammatory cytokines such as TNF-alpha and IL-1 (anti-inflammatory effect)[1][2][3]. Bioactive constituents include steroidal saponins, flavonoids (rutin, quercetin, kaempferol), polysaccharides, and amino acids. While animal and in vitro studies support these activities, clinical evidence for therapeutic efficacy remains limited, and no pharmaceutical indications are approved[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on asparagus extract.